RAPID TEST DIGITAL LIMITED
Rapid Test Digital Limited is a UK-based private company that develops patented DSR™ digital readers to automate and quantify lateral flow rapid diagnostic tests, serving healthcare providers, consumer self-testers, and resource-limited LMIC markets through hardware sales and emerging distributor partnerships in Gulf States and East Africa.
- Company typePrivate
- Founded2020
- HeadquartersDaresbury, United Kingdom
- Headcount—
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What RAPID TEST DIGITAL LIMITED does
Rapid Test Digital Limited is a UK-based private limited company (registered in England and Wales, company number 12604887) that develops and commercialises the patented DSR™ (Digital Strip Reader) technology platform for automated digital interpretation of lateral flow assay (LFA) rapid diagnostic tests. Headquartered operationally at Sci-Tech Daresbury between Manchester and Liverpool, the company offers two reader products: a single-use Disposable Reader capable of reading up to four lines, and a reusable Cartridge Reader with RFID cartridge validation and onboard memory. The technology is built on a patented Sensor Array architecture with dynamic measurement and auto-calibration, combined with a dynamic compensation algorithm that tolerates nitrocellulose quality variations and produces semi-quantitative digital outputs, addressing the well-known subjectivity problem in visual LFA interpretation.
The core innovation is the proprietary sensor array, augmented by an RFID-based smart cartridge system that authenticates cartridges and rejects non-compliant or used units, and a physical interlock that enforces correct test timing. Both readers feature USB and Bluetooth data connectivity for integration into external data processing systems, supporting remote diagnostics and disease tracking. A specific application, the Digital Pregnancy Test Kit (DPTK), applies the Disposable Reader to pregnancy testing with claimed >99% accuracy and is positioned to compete with market leaders on price, quality, reliability, and performance. The platform is broadly applicable to infectious disease, drug abuse, women's health, lifestyle, and veterinary testing via test-specific algorithm tailoring.
The business model is hardware sales of reader products, distributed through the company's own e-commerce website and via emerging distributor partnerships in target markets such as Gulf States and East Africa. The go-to-market combines direct-to-consumer online sales with a channel-partner model that places regulatory authorisation responsibility on distributors, who must also demonstrate financial backing. Target segments span healthcare providers and diagnostic laboratories, consumer self-testers, and resource-limited LMIC markets. Pricing is not publicly disclosed, no revenue, headcount, or funding rounds are reported, and the company operates without a disclosed parent or institutional investor base.
RAPID TEST DIGITAL LIMITED firmographics
Firmographics- Name
- RAPID TEST DIGITAL LIMITED
- Legal name
- Rapid Test Digital Limited
- Website
- https://rtdlimited.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Short description
- Rapid Test Digital Limited is a UK-based private company that develops patented DSR™ digital readers to automate and quantify lateral flow rapid diagnostic tests, serving healthcare providers, consumer self-testers, and resource-limited LMIC markets through hardware sales and emerging distributor partnerships in Gulf States and East Africa.
- Ownership category
- akta.pro rank
RAPID TEST DIGITAL LIMITED industry classification
Industry- Product category
- Point-of-Care Diagnostic Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro industry
- Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote DiagnosticsPregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection)Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid DiagnosticsPersonal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
Keywords
Where RAPID TEST DIGITAL LIMITED is headquartered
LocationHeadquarters
- HQ city
- Daresbury
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
RAPID TEST DIGITAL LIMITED business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- DSR Reader Hardware Sales: Sale of DSR lateral flow assay reader products including disposable readers (single-use) and cartridge readers (reusable). The cartridge reader can read up to 4 lines and supports USB charging with onboard memory for user records and test results.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels2 records
RAPID TEST DIGITAL LIMITED product offering
Product offeringCore offering
Rapid Test Digital Limited designs, manufactures and sells the patented DSR™ (Digital Strip Reader) platform — hardware readers that automate and digitise lateral flow assay rapid tests. The portfolio consists of two main reader units: the DSR™ Disposable Reader (single-use, for self-testing applications) and the DSR™ Cartridge Reader (reusable, reads up to four lines with RFID cartridge validation), together with a specific consumer application, the Digital Pregnancy Test Kit (DPTK). All products use the company's patented sensor-array technology with dynamic compensation and provide digital, semi-quantitative output via USB and Bluetooth.
Product overview
Rapid Test Digital Limited offers the DSR™ (Digital Strip Reader) technology platform for lateral flow assay rapid testing. The portfolio consists of two core reader products: the DSR™ Disposable Reader for single-use and self-testing applications, and the DSR™ Cartridge Reader for reusable multi-test use. Both readers utilize the company's patented Sensor Array technology capable of detecting multiple test lines with dynamic compensation for nitrocellulose quality variations. The Disposable Reader is designed for cost-effective self-testing with LCD readout and Bluetooth/USB connectivity, while the Cartridge Reader features RFID cartridge validation, onboard memory, and USB/Bluetooth data transfer. The Digital Pregnancy Test Kit (DPTK) is a specific application of the DSR™ technology targeting the pregnancy testing market with claimed >99% accuracy.
Differentiator
Problem solved
Functional benefit
Brands
- DSR™: Patented lateral flow assay reader technology available in Disposable Reader and Cartridge Reader formats for rapid test automation and semi-quantification.
- Digital Pregnancy Test Kit (DPTK)
Products and services
- DSR™ Disposable Reader A single-use lateral flow assay reader using patented DSR Sensor Array technology, available in single or dual formats capable of reading up to four lines. Designed to transform professional LFA testing into a self-test system, it delivers high performance reading with LCD readout and Bluetooth/USB connectivity for users performing self-tests or single-shot diagnostic readings.
- DSR™ Cartridge Reader A reusable lateral flow assay reader featuring a patented sensor array that detects multiple LFA lines, an RFID-based assay recognition system, a USB rechargeable design, onboard memory for user records and test results, and a physical interlock system for correct cartridge placement. Supports USB and Bluetooth data transfer and is aimed at multi-test professional and consumer users.
- Digital Pregnancy Test Kit (DPTK) A consumer-facing application of DSR™ disposable reader technology targeted at the pregnancy testing market. It reads very low intensity lines, provides a clear digital display, eliminates visual interpretation ambiguity, and achieves claimed over 99% accuracy, competing with market leaders on price, quality, reliability and performance.
Quantifiable outcome
- >99% Accuracy
- +3 more outcomes
Companies that use RAPID TEST DIGITAL LIMITED
Customer profileSegments3 records
Ideal customer profiles3 records
RAPID TEST DIGITAL LIMITED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
RAPID TEST DIGITAL LIMITED partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered minor.
- Distributors (Gulf States)minorTarget market for distributor partnerships in Gulf states region. Distributors must be willing to undertake approaches to regulatory authorities to secure marketing authorisation and demonstrate sound financial backing or budget for third-party regulatory engagement.
- Distributors (East Africa)minorTarget market for distributor partnerships in East Africa region. Distributors must be willing to undertake approaches to regulatory authorities to secure marketing authorisation and demonstrate sound financial backing or budget for third-party regulatory engagement.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
RAPID TEST DIGITAL LIMITED competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche operates broad rapid-test and instrumented reader programs (e.g., cobas Liat) and is a long-standing incumbent in pregnancy/fertility testing — relevant comparable for assessing RTD's eventual ceiling and competitive intensity.
- Becton Dickinson (BD Veritor): BD's Veritor Plus system is an instrumented LFA reader widely deployed in clinics and pharmacies for rapid infectious disease testing, directly comparable to RTD's reusable Cartridge Reader in functionality and POC channel.
- Siemens Healthineers (CLINITEST / Rapid Test portfolio): Siemens distributes the CLINITEST and broader rapid-test portfolio including consumer pregnancy and infectious disease tests, comparable to RTD as both compete for shelf space and POC deployment across multiple LFA verticals.
- Abbott (Clearblue / Binax): Abbott's Clearblue franchise dominates the digital pregnancy test market that RTD's DPTK explicitly targets, and its Binax rapid antigen platform represents the kind of instrumented LFA competitor RTD would face in infectious disease.
- Hologic (Diagnostics): Hologic's diagnostics portfolio (e.g., Aptima, Panther, and prior rapid-test assets) positions it as a broad incumbent in molecular and rapid diagnostics that competes for the same hospital/clinic POC budgets RTD targets with the Cartridge Reader.
- QuidelOrtho (now part of Quidel/Ortho merger, BD acquisition pending): QuidelOrtho markets the Sofia and Triage instrumented rapid-test platforms that read lateral-flow assays and provide digital results, directly competing with RTD in instrumented LFA reading for infectious disease and women's health applications.
Emerging players
- Ellume: Ellume builds digital lateral-flow diagnostics with Bluetooth-connected readers and at-home self-tests for infectious disease, a more capitalised but comparable player targeting the same intersection of LFA + digital reader + self-test use case as RTD.
Direct peers
- Axxin: Axxin builds proprietary lateral-flow assay reader instruments (e.g., T8, Palm Reader) that automate interpretation of rapid tests — directly comparable to RTD's DSR Disposable and Cartridge Readers in technology, target market (assay developers and POC users), and value proposition (digital readout, eliminating visual interpretation).
- OpTricon / Detekt Biomedical: OpTricon (operating under Detekt Biomedical) develops reader hardware and assay kits for lateral-flow rapid tests with digital readout, closely comparable to RTD in combining reader technology with proprietary assay development.
- RPS Diagnostics (now part of Mérieux NutriSciences/bioMérieux ecosystem): RPS Diagnostics developed the Sentry.io and earlier lateral-flow reader products for semi-quantitative digital readout of rapid tests — essentially the same niche RTD targets, making it one of the closest direct comparables on technology.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
RAPID TEST DIGITAL LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
RAPID TEST DIGITAL LIMITED leadership team
Management profileNumber of profiles
RAPID TEST DIGITAL LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RAPID TEST DIGITAL LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RAPID TEST DIGITAL LIMITED
What does RAPID TEST DIGITAL LIMITED do?
Rapid Test Digital Limited designs, manufactures and sells the patented DSR™ (Digital Strip Reader) platform — hardware readers that automate and digitise lateral flow assay rapid tests. The portfolio consists of two main reader units: the DSR™ Disposable Reader (single-use, for self-testing applications) and the DSR™ Cartridge Reader (reusable, reads up to four lines with RFID cartridge validation), together with a specific consumer application, the Digital Pregnancy Test Kit (DPTK). All products use the company's patented sensor-array technology with dynamic compensation and provide digital, semi-quantitative output via USB and Bluetooth.
Is RAPID TEST DIGITAL LIMITED a public or private company?
RAPID TEST DIGITAL LIMITED is a private company. It is classified as unknown and is currently operating.
When was RAPID TEST DIGITAL LIMITED founded?
RAPID TEST DIGITAL LIMITED was founded in 2020.
Where is RAPID TEST DIGITAL LIMITED based?
RAPID TEST DIGITAL LIMITED is headquartered in Daresbury, United Kingdom, in the Europe region.
How does RAPID TEST DIGITAL LIMITED make money?
One revenue line is on record: DSR Reader Hardware Sales.
Who are RAPID TEST DIGITAL LIMITED's main competitors?
Broad incumbents on record are Roche Diagnostics, Becton Dickinson (BD Veritor), Siemens Healthineers (CLINITEST / Rapid Test portfolio), Abbott (Clearblue / Binax), Hologic (Diagnostics) and QuidelOrtho (now part of Quidel/Ortho merger, BD acquisition pending). Ellume is listed as an emerging player. Direct peers are Axxin, OpTricon / Detekt Biomedical and RPS Diagnostics (now part of Mérieux NutriSciences/bioMérieux ecosystem).
Does RAPID TEST DIGITAL LIMITED have an API?
No public API is recorded for RAPID TEST DIGITAL LIMITED.
What industry is RAPID TEST DIGITAL LIMITED in?
RAPID TEST DIGITAL LIMITED's product category is Point-of-Care Diagnostic Devices. Its primary akta.pro industry code is HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers), with a secondary code of HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection). Its NAICS code is 334510 and its SIC code is 3841.